Economics of chronic heart failure

Eur J Heart Fail. 2001 Jun;3(3):283-91. doi: 10.1016/s1388-9842(01)00123-4.


Chronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF is 1-2% and appears to be increasing, in part because of ageing of the population. Economic analyses of CHF should include both direct and indirect costs of care. Healthcare expenditure on CHF in developed countries consumes 1-2% of the total health care budget. The cost of hospitalization represents the greatest proportion of total expenditure. Optimization of drug therapy represents the most effective way of reducing costs. Recent economic analyses in the Netherlands and Sweden suggest the costs of care are rising.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Costs and Cost Analysis
  • Heart Failure / economics*
  • Heart Failure / epidemiology
  • Humans